EUVIMEDOpdag EUVIMED
Open access

Novel Molecular Networks and Regulatory MicroRNAs in Type 2 Diabetes Mellitus: Multiomics Integration and Interactomics Study

Manoj Khokhar iD, Dipayan Roy iD, Sojit Tomo iD, Ashita Gadwal iD, Praveen Sharma iD, Purvi Purohit iD

JMIR Bioinformatics and Biotechnology · 2022

DOI: 10.2196/32437 ↗

At a glance

Journal article in JMIR Bioinformatics and Biotechnology, 2022. Written by Manoj Khokhar and 5 co-authors. Institution: Department of Biochemistry, All India Institute of Medical Sciences, Jodhpur, India. Cited 13 times so far (Crossref); 63 references. The full text is freely available in PubMed Central.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Type 2 diabetes mellitus (T2DM) is a metabolic disorder with severe comorbidities. A multiomics approach can facilitate the identification of novel therapeutic targets and biomarkers with proper validation of potential microRNA (miRNA) interactions.

Objective

The aim of this study was to identify significant differentially expressed common target genes in various tissues and their regulating miRNAs from publicly available Gene Expression Omnibus (GEO) data sets of patients with T2DM using in silico analysis.

Methods

Using differentially expressed genes (DEGs) identified from 5 publicly available T2DM data sets, we performed functional enrichment, coexpression, and network analyses to identify pathways, protein-protein interactions, and miRNA-mRNA interactions involved in T2DM.

Results

We extracted 2852, 8631, 5501, 3662, and 3753 DEGs from the expression profiles of GEO data sets GSE38642, GSE25724, GSE20966, GSE26887, and GSE23343, respectively. DEG analysis showed that 16 common genes were enriched in insulin secretion, endocrine resistance, and other T2DM-related pathways. Four DEGs, MAML3, EEF1D, NRG1, and CDK5RAP2, were important in the cluster network regulated by commonly targeted miRNAs (hsa-let-7b-5p, hsa-mir-155-5p, hsa-mir-124-3p, hsa-mir-1-3p), which are involved in the advanced glycation end products (AGE)-receptor for advanced glycation end products (RAGE) signaling pathway, culminating in diabetic complications and endocrine resistance.

Conclusions

This study identified tissue-specific DEGs in T2DM, especially pertaining to the heart, liver, and pancreas. We identified a total of 16 common DEGs and the top four common targeting miRNAs (hsa-let-7b-5p, hsa-miR-124-3p, hsa-miR-1-3p, and has-miR-155-5p). The miRNAs identified are involved in regulating various pathways, including the phosphatidylinositol-3-kinase-protein kinase B, endocrine resistance, and AGE-RAGE signaling pathways.

Subjects

Author keywords

bioinformaticsgene expressiongenomicsintegrative genomicsinteractomicsmiRNAmicroRNAsmultiomicsprotein-protein interactiontype 2 diabetes mellitus

Authors and institutions

  • Department of Biochemistry, All India Institute of Medical Sciences, Jodhpur, India.

ORCID profiles: Manoj Khokhar, Dipayan Roy, Sojit Tomo, Ashita Gadwal, Praveen Sharma, Purvi Purohit

Cite

APA

Khokhar, M., Roy, D., Tomo, S., Gadwal, A., Sharma, P., & Purohit, P. (2022). Novel Molecular Networks and Regulatory MicroRNAs in Type 2 Diabetes Mellitus: Multiomics Integration and Interactomics Study. JMIR Bioinformatics and Biotechnology. https://doi.org/10.2196/32437

Vancouver

Khokhar M, Roy D, Tomo S, Gadwal A, Sharma P, Purohit P. Novel Molecular Networks and Regulatory MicroRNAs in Type 2 Diabetes Mellitus: Multiomics Integration and Interactomics Study. JMIR Bioinformatics and Biotechnology. 2022. doi:10.2196/32437

BibTeX
@article{Khokhar2022,
  author = {Khokhar, Manoj and Roy, Dipayan and Tomo, Sojit and Gadwal, Ashita and Sharma, Praveen and Purohit, Purvi},
  title = {Novel Molecular Networks and Regulatory MicroRNAs in Type 2 Diabetes Mellitus: Multiomics Integration and Interactomics Study},
  journal = {JMIR Bioinformatics and Biotechnology},
  year = {2022},
  doi = {10.2196/32437}
}
Start for free →